Cargando…
Improving Colorectal Cancer Screening at an Employer-Sponsored Health Plan During the COVID-19 Pandemic
Autores principales: | Kim, Jeniffer S., Bakr, Omar, Xu, Mimi, Hochman, Michael, Pagán, Veronica M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821865/ https://www.ncbi.nlm.nih.gov/pubmed/35129771 http://dx.doi.org/10.1007/s11606-022-07426-3 |
Ejemplares similares
-
Employer and Plan Sponsor Views on Pharmacy Reimbursement
por: Stull, Michael, et al.
Publicado: (2020) -
COVID-19 Exposure Risk by Speakers of Spanish and English Using a Web-Based Self-assessment Tool
por: Mehring, William M., et al.
Publicado: (2021) -
Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic
por: Cantor, Jonathan, et al.
Publicado: (2021) -
Fluctuation, invisibility, fatigue – the barriers to maintaining employment with systemic lupus erythematosus: results of an online survey
por: Booth, S, et al.
Publicado: (2018) -
Decline and Rebound in Routine Cancer Screening Rates During the COVID-19 Pandemic
por: McBain, Ryan K., et al.
Publicado: (2021)